Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Tareq Abadl: When and Why Do We Perform Weak D Testing?
Tareq Abadl/LinkedIn
Sep 6, 2026, 10:48

Tareq Abadl: When and Why Do We Perform Weak D Testing?

Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:

“Weak D Testing: When and Why Do We Perform It?

The RhD antigen is one of the most important blood group antigens in transfusion medicine.

But sometimes, a patient’s red cells may show a weak or negative reaction with anti-D reagent despite having a reduced expression of the D antigen.

This is known as a Weak D phenotype.

What is Weak D?

Weak D occurs when the D antigen is present on the red cell surface but expressed in a lower quantity, causing weaker reactions or requiring additional testing methods for detection.

When do we perform Weak D testing?

Weak D testing is mainly important in:

Blood donors.

To prevent D-positive units from being labeled as RhD negative.

Donor units initially negative with anti-D are tested for weak D using an appropriate method.

Infants or newborns of RhD-negative mothers.

To help determine the need for Rh immune globulin (RhIG) in certain situations.

For many patient transfusion recipients, routine weak D testing is not always required and depends on laboratory policy and guidelines.

How is Weak D detected?

If the initial anti-D test is negative:

  1. Patient RBCs are incubated with anti-D reagent.
  2. An indirect antiglobulin test (IAT) phase is performed.
  3. Agglutination after AHG testing indicates a positive Weak D result.

How do we interpret the results?

Weak D Positive

  • D antigen is detected.
  • Management depends on whether the sample is from a donor, patient, or specific clinical situation.

Weak D Negative

  • No detectable D antigen by the testing method.
  • The sample is considered RhD negative.

Important laboratory point:

  • Not all weak D phenotypes behave the same.
  • Some weak D types (such as weak D type 1, 2, and 3) are generally managed as RhD positive, while some other D variants may require RhD-negative management and further investigation using RHD genotyping.

Blood Bank principle:

A weak reaction is not just a ‘weak positive.’

It may represent a clinically important RhD variant that requires proper investigation.”

Tareq Abadl

Other posts featuring Tareq Abadl on Hemostasis Today.

Blood bank Health Hematology Hemostasis Hemostasis News Hemostasis Today Immunohematology Laboratory Medicine Medicine Patient Safety RBC Tareq Abadl Weak D Weak D phenotype
NewsFeed